Zichun H. Hua
601 Jinsui Road
Xinxiang, 453003, China
Xinxiang, 453003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 130 publications
A clinical data- and AI-supported engineered fusion vesicle system for enhanced tumor-targeted drug delivery and immunochemotherapeutic synergy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 16, 2026
From tumor targeting to tumor accessibility: surface-engineered bacteria as precision living therapeutics for translational medicine.
Journal: Journal of hematology & oncology
Published: April 13, 2026
Clinical features and efficacy analysis of different treatment modalities for type Ⅰ and Ⅱ spontaneous extracranial carotid artery dissection
Journal: Zhonghua yi xue za zhi
Published: January 21, 2026
New challenges in diagnosis and treatment of chest pain in the patient with hyperuricemia.
Journal: Rheumatology advances in practice
Published: January 05, 2026
Combined physician-modified fenestration and inner branch techniques for aortic pathology with aberrant subclavian artery
Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]
Published: November 11, 2025
Superparamagnetic Fe3O4 nanoclusters for cancer therapy and metastasis prevention via synergistic chemotherapy and NETs degradation.
Journal: Biomaterials advances
Published: November 04, 2025
Controlled pyroptosis of engineered macrophages enables biphasic antitumor via the release of oncolytic bacteria and inflammatory signals.
Journal: Cell reports
Published: September 18, 2025
Amodiaquine Enhances Anti-Melanoma Efficacy of Attenuated Salmonella via Targeting Glutathione Reductase in Neutrophils.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 07, 2025
Engineered bacteria reprogram tumor microenvironment via cell senescence and neutrophil extracellular traps degradation.
Journal: Acta pharmaceutica Sinica. B
Published: July 17, 2025
An Inflammation-Targeting Engineered Probiotic Escherichia coli Nissle 1917 with High Anti-TNF-α Nanobody Secretion Efficacy Alleviates Ulcerative Colitis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 04, 2025
Correction to "Dual-Engineered Macrophage-Microbe Encapsulation for Metastasis Immunotherapy".
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: June 17, 2025
Last Updated: 09/26/2026